Although there are detailed guidelines on the use of adjuvant chemotherapy, not all patients with endocrine-positive Her2 negative breast cancer at an early stage have real benefit from adding chemotherapy to adjuvant endocrine therapy. Here, ERBB2 is linked to breast carcinoma.